Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel
you are here: HomeNewsIndia
Last Updated : Nov 20, 2020 01:31 PM IST | Source: Moneycontrol.com

Centre may send high-level teams to more states to monitor COVID-19 situation

The Centre has advised the governments of states and union territories to increase COVID-19 testing to detect missing positive cases

Representative image
Representative image

The central government is considering sending high-level multidisciplinary teams to other states and union territories that are reporting a rise in COVID-19 cases to support efforts towards strengthening containment, surveillance, testing and efficient clinical management of positive cases.

The Centre has advised the governments of states and union territories to increase COVID-19 testing to detect missing positive cases, reported CNN News18 citing health ministry sources. An increase in testing will ensure fall in positivity rate, said the government, as per the report.

It has already rushed such teams to districts of Haryana, Rajasthan, Gujarat and Manipur registering a high number of coronavirus infections.

Close

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

On November 19, the Union Health Ministry said with the spike in daily new COVID-19 cases and fatalities in Delhi, the spillover effect is being observed in the NCR regions within Haryana and Rajasthan where the number of COVID-19 positive patients is on the rise

Dr Randeep Guleria, Director of All India Institute of Medical Sciences (AIIMS), New Delhi is leading the three-member team to Haryana and Dr V K Paul, Member (Health), Niti Aayog is heading the Rajasthan team. Dr SK Singh, Director (NCDC) will be leading the team to Gujarat while Dr L Swasticharan, Additional DDG, DHGS is heading the Manipur team.

Follow our full coverage on COVID-19 here.

The teams have been tasked to visit the districts reporting a high number of COVID-19 cases and support the state’s efforts towards strengthening containment, surveillance, testing, infection prevention and control measures, and efficient clinical management of positive cases.

The central teams will also guide in effectively managing the challenges related to timely diagnosis and follow up, the ministry said.

(With inputs from PTI)
First Published on Nov 20, 2020 01:31 pm
Sections